New method identifies genes that can predict prognoses of cancer patients
In recent years, it has been thought that select sets of genes might reveal cancer patients' prognoses. However, a study published last year examining breast cancer cases found that most of these "prognostic signatures" were ...
Genetics
Jan 25, 2013 |
not rated yet |
0
Gene sequencing project mines data once considered 'junk' for clues about cancer
Genome sequencing data once regarded as junk is now being used to gain important clues to help understand disease. The latest example comes from the St. Jude Children's Research Hospital – Washington University Pediatric ...
Cancer
Jan 24, 2013 |
5 / 5 (2) |
0
|
Discovering the secrets of tumor growth
Scientists at the University of Copenhagen's Center for Healthy Ageing have identified a compound that blocks the expression of a protein without which certain tumours cannot grow. This compound has the potential as an anticancer ...
Cancer
Jan 24, 2013 |
not rated yet |
0
Helping healthy cells could be key to fighting leukemia, research suggests
Researchers at Imperial College London have shown that keeping healthy blood cells alive could be a more important tool in the fight against leukaemia than keeping cancerous cells at bay.
Cancer
Jan 22, 2013 |
5 / 5 (1) |
0
How can evolutionary biology explain why we get cancer?
Over 500 billion cells in our bodies will be replaced daily, yet natural selection has enabled us to develop defenses against the cellular mutations which could cause cancer. It is this relationship between evolution and ...
Cancer
Jan 22, 2013 |
not rated yet |
0
The new age of proteomics: An integrative vision of the cellular world
The enormous complexity of biological processes requires the use of highperformance technologies —also known as 'omics'—, that are capable of carrying out complete integrated analyses of the thousands of molecules ...
Genetics
Jan 17, 2013 |
1 / 5 (1) |
1
Cancer biology: Keeping bad company
The p53 tumor suppressor protein manages DNA repair mechanisms in response to genetic damage and kills off precancerous cells before they multiply. The loss of p53 due to mutation greatly increases risk of ...
Cancer
Jan 16, 2013 |
not rated yet |
0
Scientists reveal aggressive breast cancer's metastatic path
Scientists at Weill Cornell Medical College have discovered the molecular switch that allows aggressive triple negative breast cancer cells to grow the amoeba-like protrusions they need to crawl away from a primary tumor ...
Cancer
Jan 14, 2013 |
5 / 5 (2) |
0
|
Breakthrough in understanding of how cancer treatment drugs affect cells
(Medical Xpress)—A young Victoria University scientist is part of a team whose work has been published in the prestigious international magazine Science, for research that will open doors to developing much more effect ...
Cancer
Jan 14, 2013 |
5 / 5 (2) |
0
|
Cancer suppressor gene links metabolism with cellular aging
The tumor suppressor protein p53 is an attractive target for drug developers. But this path has so far proven difficult, as most p53 regulatory proteins operate via protein-protein interactions, which make for poor drug targets, ...
Cancer
Jan 13, 2013 |
3.7 / 5 (3) |
0
|
Computer model helps researchers hunt out cancer-causing mutational signatures in the genome
(Medical Xpress)—Researchers from the Wellcome Trust Sanger Institute's cancer genome project have developed a computer model to identify the fingerprints of DNA-damaging processes that drive cancer development. ...
Genetics
Jan 11, 2013 |
not rated yet |
0
|
Nutritional supplement may help prevent Alzheimer's, research suggests
(Medical Xpress)—A nutritional supplement available over-the-counter may offer protection from Alzheimer's disease, a study by the University of Virginia and Northwestern University suggests.
Alzheimer's disease & dementia
Jan 10, 2013 |
4.2 / 5 (11) |
0
|
Drug-resistant melanoma tumors shrink when therapy is interrupted
Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation ...
Cancer
Jan 09, 2013 |
3.7 / 5 (3) |
0
|
Multiple sclerosis drug may one day treat colorectal cancer
After uncovering a mechanism that promotes chronic intestinal inflammation and the development of colorectal cancer, scientists from Virginia Commonwealth University Massey Cancer Center have found that fingolimod, ...
Cancer
Jan 09, 2013 |
not rated yet |
0
|
Healthy BMI levels, physical activity linked to endometrial cancer survival
(Medical Xpress)—Higher body mass index (BMI) and physical inactivity are associated with more than a two-fold increase in risk for mortality among women with endometrial cancer, new research by the Yale ...
Cancer
Jan 08, 2013 |
not rated yet |
0
|
